|
|
1.INTRODUCTIONWith the emergence of new technologies in the field of tissue engineering and regenerative medicine, the prospect of making personalized functional human tissues and organ substitutes can be realized. Among the different strategies and techniques available to tissue engineers, the area of 3D bioprinting has created a paradigm shift by giving researchers a versatile tool to build a wide range of complex tissues that recapitulate the in vivo cellular heterogeneity, microarchitectures, biophysical properties, and biochemical constituents. More specifically, 3D bioprinting provides a method to precisely control the patterning of different cell types and biomaterials such that they represent the biophysical arrangement of native tissues. To date, a plethora of tissues have been fabricated using 3D bioprinting technology including but not limited to the liver, heart, lung, kidney, blood vessels, cartilage, and placenta 1–7. In turn, these bioprinted tissues have important implications in various biological and medical disciplines ranging from physiologically relevant models for elucidating biological mechanisms and drug screening, to integration with biosensors and microfluidics for lab-on-a-chip devices as well as transplantable tissues for clinical applications. In this article, we will discuss the current state of 3D printing systems followed by highlighting our current work on 3D bioprinted prevascularized tissue constructs as well a 3D bioprinted hepatic model, and finally discussing the future of next-generation decellularized extracellular matrix (dECM) bioinks as tissue-specific biomaterials to facilitate the development of more physiologically-relevant tissues. 2.DMD-BASED 3D BIOPRINTINGCurrently, there are several different 3D printing platforms available which can be categorized as inkjet-based printers, extrusion-based printers, laser-based stereolithography, and digital micro-mirror array device (DMD)-based printers with each varying in terms of print resolution, speed, and biomaterial compatibility. One of the most commonly used is the traditional 3D inkjet printer that was first adopted from the common desktop ink-based paper printers, in which biomaterials and cells are deposited in a raster-like manner 8. By using acoustic, thermal, or electrostatic forces, inkjet printers deposit materials drop-by-drop through a fine nozzle onto a receiving substrate placed on a movable stage. These printers are relatively low cost, capable of micron scale printing resolutions (~50 μm), and limited to using low viscosity materials 9. Similarly, extrusion-based printers work by depositing materials through a nozzle tip using pneumatic or mechanical pressure upon which the material solidifies on contact with the receiving substrate. These printers can achieve feature size from 5 μm to a few millimeters wide with moderate speeds of fabrication, and can accommodate a larger range of material viscosities and higher cell densities compared to inkjet printers 10,11. Furthermore, laser-based stereolithography utilizes laser-induced photopolymerization to polymerize materials in a contactless iterative fashion. Here, microstructures with overhanging features can be produced possessing micro and nanoscale resolutions 12,13. While these printing systems are well-established, they have shortcomings in terms of fabrication speed, limited range of compatible materials, potential for clogging or decreased cell viability due to shear stress, and scalability. In more recent years, DMD-based 3D bioprinters have enabled a more rapid approach for the microfabrication of complex structures as well as improved spatial resolution not attainable by the nozzle and inkjet based printing systems. In general, slices of the object are digitized into a series of light patterns which are then projected by a DMD to a pre-polymer solution. The DMD containing millions of micro-mirrors (e.g. 1920×1080) for light projection enables massively parallel printing without the need of point-by-point scanning. By using this technique an entire plane of an object can be fabricated at once, and as the z-stage moves continuously, the 3D structure can be built continuously, resulting in smooth features and the elimination of artifacts between adjacent layers normally encountered with traditional 3D printing approaches. For instance, both dynamic optical projection stereolithography (DOPsL)-based and continuous liquid interphase production (CLIP)-based printing technologies adopt these principles. High resolutions of 3-5 μm in the x-y direction can be achieved using the DOPsL-based method 14. Furthermore, CLIP-based printers have been shown to be able to form complex overhanging structures with less than 100 μm resolution and produce large constructs on the centimeter scale 15. In general, DMD-based printers can produce printed structures with micron scale resolution in mere seconds and have been demonstrated to be well-suited for cell encapsulation to form biomimetic tissue constructs 1,5,12,14,15. 3.3D BIOPRINTING OF PREVASCULARIZED TISSUE CONSTRUCTSAs the 3D bioprinting field advances towards the generation of larger and more complex tissues for in vivo transplantation, there is a critical need for the ability to vascularize these tissue constructs in order to maintain long term viability and function 16. One approach is incorporate pro-angiogenic growth factors to induce host vascularization into the tissue construct, however, this process is slow and leads to decreased cell viability after initial transplantation 17,18. As such, it has been recognized that a preexisting vascular network would be a more favorable strategy to accelerate the vascularization process by allowing the host to directly anastomose to the graft and improve cell viability, blood perfusion, and vascularization 16,19. While many methods have been demonstrated to create prevascularized tissues such as with the use of sacrificial materials and micromolding techniques, they are time consuming and require multiple steps which may not lend well for large-scale production. In our work, we utilized a rapid DMD-based microscale continuous optical bioprinter (μCOB) to produce prevascularized tissue constructs directly in a one-step manner by patterning endothelial cells into complex hierarchal vascular branched networks (Fig. 1) 5. Specifically, we bioprinted a vascular bioink composed of human umbilical endothelial cells (HUVECs) and 10T1/2 cells (50:1 ratio) in a naturally-derived prepolymer solution comprised of photopolymerizable gelatin methacrylate (GelMA) and glycidal methacrylate hyaluronic acid (GM-HA) with lithium phenyl-2,4,6 trimethylbenzoylphosphinate (LAP) as the photoinitator. The entire printing process can be accomplished in less than one minute using our technique with high resolution and complex microarchitecture of heterogeneous cellular components (Fig. 1 D-I), such that endothelial regions were patterned within the surrounding hepatocellular regions containing HepG2 cells. After one-week in vitro culture, the bioprinted prevascularized tissue constructs maintained good structural integrity along with high cellular viability of over 85%. Furthermore, immunohistochemical stains for human-specific CD31 and α-smooth muscle actin (Fig. 1 J-L) of the hierarchal bioprinted tissue constructs with varying vessel diameters ranging from approximately 50 to 250 μm, demonstrated the induction of 10T1/2 cells adopting a pericyte phenotype with the HUVECs lining the outer walls of the vessel patterns and forming a lumen-like structure in one week. To assess the efficacy of our bioprinted prevascularized tissue constructs to form endothelial networks in vivo, we implanted them subcutaneously in the dorsal region of severe combined immunodeficiency (SCID) mice. After two weeks post-surgery, histological images revealed an increased number of visibly mature endothelial vasculature with red blood cells present within the lumens (Fig. 2A) as compared to non-prevascularized tissue controls (Fig. 2B). This is further supported by measurements of the vascular density and average vessels counts per area in the graft region showing a significant increase for the prevascularized tissue constructs in both cases (Fig. 2C,D). To evaluate the anastomosis of the bioprinted prevascularized construct to the host vasculature, SCID mice were administered with mouse-specific lectin (HPA) and human-specific lectin (UEA) to differentiate between mouse and human endothelial cells, respectively. Fluorescent images shown in Fig. 2E indicated that regions within the prevascularized tissue implant stained positive for both HPA and UEA, thus confirming the presence of cells originating from the host and graft in the vessels. Further staining of human von Willebrand factor (hVWF) confirmed the endothelial network formed by human origin HUVECs. In contrast, for non-prevascularized tissue controls only HPA positive staining was observed in the host tissue regions and in the outer borders of the construct, and no UEA or hVWF staining was observed. Overall, these results demonstrate that the prevascularized networks integrated and anastomosed to the host vascular system and was able to support blood perfusion. This study showcases a simple and efficient method of applying DMD-based 3D bioprinting techniques to rapidly fabricate intricate vascular networks directly within tissues constructs. The flexibility of our 3D bioprinting platform also allows the potential to engineer more complex heterogeneous tissues through the incorporation of other cell types and photopolymerizable biomaterials, in addition to the scalability of this approach to fabricate large tissue constructs. The biocompatibility and anastomosis to the host observed from the in vivo studies also demonstrates the significant potential of these prevascularized tissue constructs to serve as tissue grafts for the future goal of producing transplantable tissue or organ substitutes in tissue engineering and regenerative medicine. 4.3D BIOPRINTING OF A BIOMIMETIC HUMAN IPSC-DERIVED HEPATIC MODELOne of the key aspects towards the creation of truly biomimetic tissues is the need to recapitulate the heterogeneous cell population composed of parenchymal cells, stromal cells, and other supportive nonparenchymal cells. This concept derives from the fact that multiple cell types co-exist in vivo and communicate through paracrine signaling with each other as well as their interactions with the surrounding extracellular matrix (ECM) microenvironment to form a functional tissue unit 20. As such, 3D bioprinting technologies offer a precise way to pattern various cell types to essentially build a tissue using a bottom-up approach. While cell patterning is crucial, their sourcing is also of great importance in the context of creating physiologically relevant tissue models. The majority of printed tissues to date have been produced using established cell lines or animal-derived cell sources to serve as a proof-of-concept, however, these cells do not fully reflect the behavior and function of human primary cells 21. With the advent of human induced pluripotent stem cells (hiPSCs) and their ability to differentiate into a multiple cell types including cardiac, liver, kidney, and neuronal cells, their use in 3D bioprinting would be of great importance due to their abundance and stability 22. To address these challenges as well as expand our work on prevascularized tissue constructs, our group 3D bioprinted the first in vitro biomimetic hepatic model that recapitulates the native microenvironment through the use of multiple human-derived cell types patterned in a complex microarchitecture. Our 3D hepatic triculture model incorporated hiPSC-derived hepatic progenitor cells (hiPSC-HPCs) in the lobular regions in conjunction with HUVECs and human adipose-derived stem cells (ADSCs) in the surrounding vascular network. Furthermore, two naturally-derived photopolymerizable hydrogels were chosen in which GelMA was used for the hepatic component and GelMA + GM-HA was used for the vascular component. After patterning the hiPSC-HPCs and the endothelial cells via a two-step printing process (Fig. 3A,B), the microscale hexagonal microarchitecture can be clearly observed to reflect the tissue-scale anatomical features and dimensions of the liver in our design (Fig. 3C). To assess the structural integrity of the bioprinted 3D triculture hepatic construct, cells were fluorescently tracked over 10 days in vitro culture. Interestingly, the cells remained within each of their patterned regions for at least 10 days post-printing and integrated into a single construct over time (Fig. 4A). Moreover, immunohistochemical staining of albumin (ALB) and E-cadherin (E-cad) in the 3D hepatic triculture constructs revealed larger aggregation and spheroid formation over time as compared to hiPSC-HPC only controls (Fig. 4B). These observations suggested a higher degree of cell junction formation as well as maturation and functionality, which was further supported by the gene expression profile (Fig. 5A) demonstrating higher levels of the key liver markers: albumin (ALB), hepatocyte nuclear factor 4 alpha (HNFa), transthyretin (TTR), and alpha fetal protein (AFP) relative to the 3D hiPSC-HPC only and 2D monolayer controls. To further assess the functionality of our 3D hepatic triculture model, quantification of albumin concentration and urea production also confirmed that significantly higher secretion levels for both were observed across 20 days of in vitro culture compared to 3D hiPSC-HPC only and 2D monolayer controls (Fig. 5B,C). To evaluate the potential for our 3D hepatic triculture model to serve as platform for drug screening, the anabolic and catabolic functions of our model was assessed by examining the upregulation of expression of key CYP enzymes that are involved in liver drug metabolism (Fig. D) 23. Baseline CYP levels without drug treatment showed that our 3D triculture model had significantly elevated levels of CYP3A4 expression and higher levels of CYP1A2, CYP2B6, CYP2C9, and CYP2C19 compared to the 3D hiPSC-HPC only and 2D culture controls. Upon introducing rifampicin, a known bactericidal antibiotic drug to induce hepatotoxicity 24, our 3D triculture hepatic model exhibited increased CYP3A4, CYP2C9, and CYP2C19 expression in comparison to untreated controls. In contrast, no significant increases in the CYP enzyme expression was observed for the 3D hiPSC-HPC only and 2D culture controls. Overall, we demonstrated the utility of our DLP-based 3D bioprinter to produce a complex functional 3D biomimetic hepatic triculture model that recapitulates both the native liver microarchitecture and cellular diversity. More importantly, the improved albumin and urea secretion as well as drug response in our 3D triculture model further supports the importance of including supportive cells to facilitate in vitro functionality and maturation. The incorporation of human iPSC-HPCs in our model also demonstrates the potential for our platform to be used for personalized medicine as a patient-specific approach to study various pathophysiological disease mechanisms, drug screening and discovery applications, as well as for clinical translation. 5.3D BIOPRINTING OF DECELLULARIZED EXTRACELLULAR MATRIX AS NEXT-GENERATION BIOINKSWith the growing advancements in 3D bioprinting technology, the generation of novel biomaterials to serve as cell supportive bioinks is critical to better mimic the native niche microenvironment. In vivo, cells actively interact with the surrounding extracellular matrix (ECM), which functions both as a structural support and a rich reservoir for biochemical constituents including growth factors, cell-binding proteins, collagens, and proteoglycans 25. In turn, these cell-ECM interactions regulate cell behavior such as proliferation, differentiation, maturation, and migration 25. Studies characterizing the ECM have also elucidated its diversity such that they vary compositionally between different tissues and organs 26,27. As such, the hypothesis that recapitulating the tissue-specific ECM will improve cell response and behavior has served as a foundational basis for the development of novel biomaterials. To address the challenge of creating a tissue-specific ECM, an attractive approach is to preserve the inherent complex native ECM constituents using a decellularization process. In general, tissues and organs are decellularized through a combination of detergent and enzymatic washes as well as mechanical disruption to yield a ECM scaffold that is devoid of cellular content. By undergoing this process, many protocols to date have been established to form a wide range of decellularized tissues including the heart, liver, kidney, adipose, bone, and cartilage 28–33. Importantly, in vitro studies have also demonstrated that tissue-specific decellularized scaffolds improve the proliferation, differentiation, and maintenance of cell phenotype of cultured tissue-matched cell types 26,34,35. For instance, ADSCs cultured on 3D decellularized adipose tissue foams showed enhanced adipogenic differentiation in terms of lipid accumulation, GPDH activity, and upregulation of the key adipogenic genes PPARγ, CEBPα, and LPL compared to 2D controls 36. This is also further supported by the increased proliferation and maintenance of stem cell phenotype of ADSCs expanded on decellularized adipose tissue microcarriers over long term culture compared to collagen-based Cultispher-S® microcarrier controls 34. While the exact mechanism is unknown, it is believed that the complex nature of the tissue-specific ECM provides an environment more similar to their natural in vivo microenvironment and therefore contributes as an improved cell-instructive substrate. This observation is further supported by a study demonstrating enhanced cell adhesion and proliferation as well as phenotype maintenance when liver, muscle, and skin cells were grown on tissue-matched decellularized ECM coatings versus non-tissue matched controls 26. As such, the application of decellularized tissues to serve as tissue-specific bioinks in 3D bioprinting would have great potential towards the advancements of producing biomimetic tissues and organs. Currently, the selection of naturally-derived bioinks available for 3D bioprinting has been limited to biomaterials such as gelatin, collagen, alginate, fibrin, chitosan, and hyaluronic acid 37, which are simple in composition compared to the native ECM. By developing printable decellularized tissue bioinks compatible with different 3D bioprinters (e.g. extrusion-based or DLP-based printers), the generation of a large library of bioinks tailored for various engineered tissues and organs can be readily accomplished 38. In particular, it can be envisioned that these tissue-specific decellularized ECM bioinks could be used directly in their pure form or incorporated with other existing bioinks to enhance their functional properties. Overall, decellularized ECM offers a unique strategy to be able to preserve the innate complexity of the tissue-specific microenvironment with potential to improve the functionality of biomimetic tissues that would otherwise be difficult to achieve using a bottom-up approach. 6.CONCLUSIONSIn summary, 3D bioprinting technology in recent years have led to the breakthrough development of multiple tissue models for a wide range of applications in tissue engineering and regenerative medicine. More specifically, using our DLP-based 3D bioprinters we developed novel approaches to rapidly fabricate complex tissue structures that possess microscale resolution and physiologically relevant architectures. Namely, we were able to directly print cellularized hierarchal branched vascular networks that were able to support host anastomosis and blood perfusion in vivo, which demonstrates the potential clinical translation of bioprinted tissues. Our lab has also developed the first human biomimetic 3D hepatic triculture model composed of human iPSC-derived hepatic progenitor cells for use as a clinically-relevant platform for personalized medicine and drug screening applications. In general, the future direction of 3D bioprinting functional tissues and organs will involve the incorporation of multiple facets namely the inclusion of heterogeneous cell populations placed in their anatomical locale, intricate vascular networks to maintain long term growth and maturation of the tissue, and the incorporation of bioactive naturally-derived bioinks, such as decellularized ECM, to provide a complex tissue-specific microenvironment to enhance functionality. ACKNOWLEDGEMENTSWe thank the grant support from the National Institutes of Health (R33HD090662 and R01EB021857), and National Science Foundation (1903933 and 1644967) to S.C. REFERENCESMa, X., Qu, X., Zhu, W., Li, Y.-S., Yuan, S., Zhang, H., Liu, J., Wang, P., Lai, C. S. E., Zanella, F., Feng, G.-S., Sheikh, F., Chien, S. and Chen, S.,
“Deterministically patterned biomimetic human iPSC-derived hepatic model via rapid 3D bioprinting,”
in Proceedings of the National Academy of Sciences,
2206
–2211
(2016). Google Scholar
Lind, J. U., Busbee, T. A., Valentine, A. D., Pasqualini, F. S., Yuan, H., Yadid, M., Park, S.-J., Kotikian, A., Nesmith, A. P., Campbell, P. H., Vlassak, J. J., Lewis, J. A. and Parker, K. K.,
“Instrumented cardiac microphysiological devices via multimaterial three-dimensional printing,”
Nature Materials, 16
(3), 303
–308
(2016). https://doi.org/10.1038/nmat4782 Google Scholar
Eisenstein, M.,
“Artificial organs: Honey, I shrunk the lungs,”
Nature, 519
(7544), S16
–S18
(2015). https://doi.org/10.1038/519S16a Google Scholar
Homan, K. A., Kolesky, D. B., Skylar-Scott, M. A., Herrmann, J., Obuobi, H., Moisan, A. and Lewis, J. A.,
“Bioprinting of 3D Convoluted Renal Proximal Tubules on Perfusable Chips,”
Scientific Reports, 6
(1), 34845
(2016). https://doi.org/10.1038/srep34845 Google Scholar
Zhu, W., Qu, X., Zhu, J., Ma, X., Patel, S., Liu, J., Wang, P., Sun, C., Lai, E., Gou, M., Xu, Y., Zhang, K. and Chen, S.,
“Direct 3D bioprinting of prevascularized tissue constructs with complex microarchitecture,”
Biomaterials, 124 106
–115
(2017). https://doi.org/10.1016/j.biomaterials.2017.01.042 Google Scholar
Nguyen, D., Hägg, D. A., Forsman, A., Ekholm, J., Nimkingratana, P., Brantsing, C., Kalogeropoulos, T., Zaunz, S., Concaro, S., Brittberg, M., Lindahl, A., Gatenholm, P., Enejder, A. and Simonsson, S.,
“Cartilage Tissue Engineering by the 3D Bioprinting of iPS Cells in a Nanocellulose/Alginate Bioink,”
Scientific Reports, 7
(1), 658
(2017). https://doi.org/10.1038/s41598-017-00690-y Google Scholar
Kuo, C.-Y., Eranki, A., Placone, J. K., Rhodes, K. R., Aranda-Espinoza, H., Fernandes, R., Fisher, J. P. and Kim, P. C. W.,
“Development of a 3D Printed, Bioengineered Placenta Model to Evaluate the Role of Trophoblast Migration in Preeclampsia,”
ACS Biomaterials Science & Engineering, 2
(10), 1817
–1826
(2016). https://doi.org/10.1021/acsbiomaterials.6b00031 Google Scholar
Wilson, W. C. and Boland, T.,
“Cell and organ printing 1: Protein and cell printers,”
The Anatomical Record, 272A
(2), 491
–496
(2003). https://doi.org/10.1002/(ISSN)1097-0185 Google Scholar
Xu, T., Zhao, W., Zhu, J.-M., Albanna, M. Z., Yoo, J. J. and Atala, A.,
“Complex heterogeneous tissue constructs containing multiple cell types prepared by inkjet printing technology,”
Biomaterials, 34
(1), 130
–139
(2013). https://doi.org/10.1016/j.biomaterials.2012.09.035 Google Scholar
Blaeser, A., Duarte Campos, D. F., Puster, U., Richtering, W., Stevens, M. M. and Fischer, H.,
“Controlling Shear Stress in 3D Bioprinting is a Key Factor to Balance Printing Resolution and Stem Cell Integrity,”
Advanced Healthcare Materials, 5
(3), 326
–333
(2016). https://doi.org/10.1002/adhm.v5.3 Google Scholar
Murphy, S. V and Atala, A.,
“3D bioprinting of tissues and organs,”
Nature Biotechnology, 32
(8), 773
–785
(2014). https://doi.org/10.1038/nbt.2958 Google Scholar
Zhang, W., Han, L.-H. and Chen, S.,
“Integrated Two-Photon Polymerization With Nanoimprinting for Direct Digital Nanomanufacturing,”
Journal of Manufacturing Science and Engineering, 132
(3), 030907
(2010). https://doi.org/10.1115/1.4001661 Google Scholar
Paz, V. F., Emons, M., Obata, K., Ovsianikov, A., Peterhänsel, S., Frenner, K., Reinhardt, C., Chichkov, B., Morgner, U. and Osten, W.,
“Development of functional sub-100 nm structures with 3D two-photon polymerization technique and optical methods for characterization,”
Journal of Laser Applications, 24
(4), 042004
(2012). https://doi.org/10.2351/1.4712151 Google Scholar
Zhang, A. P., Qu, X., Soman, P., Hribar, K. C., Lee, J. W., Chen, S. and He, S.,
“Rapid Fabrication of Complex 3D Extracellular Microenvironments by Dynamic Optical Projection Stereolithography,”
Advanced Materials, 24
(31), 4266
–4270
(2012). https://doi.org/10.1002/adma.v24.31 Google Scholar
Tumbleston, J. R., Shirvanyants, D., Ermoshkin, N., Janusziewicz, R., Johnson, A. R., Kelly, D., Chen, K., Pinschmidt, R., Rolland, J. P., Ermoshkin, A., Samulski, E. T. and DeSimone, J. M.,
“Continuous liquid interface production of 3D objects,”
Science, 347
(6228), 1349
–1352
(2015). https://doi.org/10.1126/science.aaa2397 Google Scholar
Lovett, M., Lee, K., Edwards, A. and Kaplan, D. L.,
“Vascularization strategies for tissue engineering.,”
Tissue engineering. Part B, Reviews, 15
(3), 353
–370
(2009). https://doi.org/10.1089/ten.teb.2009.0085 Google Scholar
Fischbach, C. and Mooney, D. J.,
“Polymers for pro- and anti-angiogenic therapy.,”
Biomaterials, 28
(12), 2069
–2076
(2007). https://doi.org/10.1016/j.biomaterials.2006.12.029 Google Scholar
Lee, K. Y., Peters, M. C., Anderson, K. W. and Mooney, D. J.,
“Controlled growth factor release from synthetic extracellular matrices,”
Nature, 408
(6815), 998
–1000
(2000). https://doi.org/10.1038/35050141 Google Scholar
Chen, X., Aledia, A. S., Ghajar, C. M., Griffith, C. K., Putnam, A. J., Hughes, C. C. W. and George, S. C.,
“Prevascularization of a Fibrin-Based Tissue Construct Accelerates the Formation of Functional Anastomosis with Host Vasculature,”
Tissue Engineering Part A, 15
(6), 1363
–1371
(2009). https://doi.org/10.1089/ten.tea.2008.0314 Google Scholar
Thorne, J. T., Segal, T. R., Chang, S., Jorge, S., Segars, J. H. and Leppert, P. C.,
“Dynamic Reciprocity Between Cells and Their Microenvironment in Reproduction1,”
Biology of Reproduction, 92
(1),
(2015). https://doi.org/10.1095/biolreprod.114.121368 Google Scholar
Kaur, G. and Dufour, J. M.,
“Cell lines: Valuable tools or useless artifacts.,”
Spermatogenesis, 2
(1), 1
–5
(2012). https://doi.org/10.4161/spmg.19885 Google Scholar
Martins-Taylor, K. and Xu, R.-H.,
“Concise Review: Genomic Stability of Human Induced Pluripotent Stem Cells,”
STEM CELLS, 30
(1), 22
–27
(2012). https://doi.org/10.1002/stem.v30.1 Google Scholar
Guengerich, F. P.,
“Cytochrome P-450 3A4: Regulation and Role in Drug Metabolism,”
Annual Review of Pharmacology and Toxicology, 39
(1), 1
–17
(1999). https://doi.org/10.1146/pharmtox.1999.39.issue-1 Google Scholar
Faucette, S. R., Wang, H., Hamilton, G. A., Jolley, S. L., Gilbert, D., Lindley, C., Yan, B., Negishi, M. and LeCluyse, E. L.,
“Regulation of CYP2B6 in primary human hepatocytes by prototypical inducers,”
Drug Metabolism and Disposition, 32
(3), 348
–358
(2004). https://doi.org/10.1124/dmd.32.3.348 Google Scholar
Crapo, P. M., Gilbert, T. W. and Badylak, S. F.,
“An overview of tissue and whole organ decellularization processes,”
Biomaterials, 32
(12), 3233
–3243
(2011). https://doi.org/10.1016/j.biomaterials.2011.01.057 Google Scholar
Zhang, Y., He, Y., Bharadwaj, S., Hammam, N., Carnagey, K., Myers, R., Atala, A. and Van Dyke, M.,
“Tissue-specific extracellular matrix coatings for the promotion of cell proliferation and maintenance of cell phenotype,”
Biomaterials, 30
(23–24), 4021
–4028
(2009). https://doi.org/10.1016/j.biomaterials.2009.04.005 Google Scholar
Russo, V., Yu, C., Belliveau, P., Hamilton, A. and Flynn, L. E.,
“Comparison of Human Adipose-Derived Stem Cells Isolated from Subcutaneous, Omental, and Intrathoracic Adipose Tissue Depots for Regenerative Applications,”
STEM CELLS Translational Medicine, 3
(2), 206
–217
(2014). https://doi.org/10.5966/sctm.2013-0125 Google Scholar
Ott, H. C., Matthiesen, T. S., Goh, S.-K., Black, L. D., Kren, S. M., Netoff, T. I. and Taylor, D. A.,
“Perfusion-decellularized matrix: using nature’s platform to engineer a bioartificial heart,”
Nature Medicine, 14
(2), 213
–221
(2008). https://doi.org/10.1038/nm1684 Google Scholar
Mazza, G., Rombouts, K., Rennie Hall, A., Urbani, L., Vinh Luong, T., Al-Akkad, W., Longato, L., Brown, D., Maghsoudlou, P., Dhillon, A. P., Fuller, B., Davidson, B., Moore, K., Dhar, D., De Coppi, P., Malago, M. and Pinzani, M.,
“Decellularized human liver as a natural 3D-scaffold for liver bioengineering and transplantation,”
Scientific Reports, 5
(1), 13079
(2015). https://doi.org/10.1038/srep13079 Google Scholar
Yu, Y. L., Shao, Y. K., Ding, Y. Q., Lin, K. Z., Chen, B., Zhang, H. Z., Zhao, L. N., Wang, Z. B., Zhang, J. S., Tang, M. L. and Mei, J.,
“Decellularized kidney scaffold-mediated renal regeneration,”
Biomaterials, 35
(25), 6822
–6828
(2014). https://doi.org/10.1016/j.biomaterials.2014.04.074 Google Scholar
Flynn, L. E.,
“The use of decellularized adipose tissue to provide an inductive microenvironment for the adipogenic differentiation of human adipose-derived stem cells,”
Biomaterials, 31
(17), 4715
–4724
(2010). https://doi.org/10.1016/j.biomaterials.2010.02.046 Google Scholar
Chen, G. and Lv, Y.,
“Decellularized Bone Matrix Scaffold for Bone Regeneration,”
Methods in molecular biology,
(2017). https://doi.org/10.1007/978-1-4939-7656-0 Google Scholar
Schwarz, S., Koerber, L., Elsaesser, A. F., Goldberg-Bockhorn, E., Seitz, A. M., Dürselen, L., Ignatius, A., Walther, P., Breiter, R. and Rotter, N.,
“Decellularized cartilage matrix as a novel biomatrix for cartilage tissue-engineering applications.,”
Tissue engineering. Part A, 18
(21–22), 2195
–2209
(2012). https://doi.org/10.1089/ten.tea.2011.0705 Google Scholar
Yu, C., Kornmuller, A., Brown, C., Hoare, T. and Flynn, L. E.,
“Decellularized adipose tissue microcarriers as a dynamic culture platform for human adipose-derived stem/stromal cell expansion,”
Biomaterials, 120 66
–80
(2017). https://doi.org/10.1016/j.biomaterials.2016.12.017 Google Scholar
Fong, A. H., Romero-López, M., Heylman, C. M., Keating, M., Tran, D., Sobrino, A., Tran, A. Q., Pham, H. H., Fimbres, C., Gershon, P. D., Botvinick, E. L., George, S. C. and Hughes, C. C. W.,
“Three-Dimensional Adult Cardiac Extracellular Matrix Promotes Maturation of Human Induced Pluripotent Stem Cell-Derived Cardiomyocytes.,”
Tissue engineering. Part A, 22
(15–16), 1016
–1025
(2016). https://doi.org/10.1089/ten.tea.2016.0027 Google Scholar
Yu, C., Bianco, J., Brown, C., Fuetterer, L., Watkins, J. F., Samani, A. and Flynn, L. E.,
“Porous decellularized adipose tissue foams for soft tissue regeneration,”
Biomaterials, 34
(13), 3290
–3302
(2013). https://doi.org/10.1016/j.biomaterials.2013.01.056 Google Scholar
Chia, H. N. and Wu, B. M.,
“Recent advances in 3D printing of biomaterials,”
Journal of Biological Engineering, 9
(1), 4
(2015). https://doi.org/10.1186/s13036-015-0001-4 Google Scholar
Pati, F., Jang, J., Ha, D.-H., Won Kim, S., Rhie, J.-W., Shim, J.-H., Kim, D.-H. and Cho, D.-W.,
“Printing three-dimensional tissue analogues with decellularized extracellular matrix bioink,”
Nature Communications, 5 3935
(2014). https://doi.org/10.1038/ncomms4935 Google Scholar
|